Laboratory Animals > Volume 42, Number 3 > Pp. 338-349

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Francis, R. C E Articles by Boemke, W. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Papers

The haemodynamic and catecholamine response to xenon/remifentanil anaesthesia in Beagle dogs

Roland C E Francis ^* , Matthias S Reyle-Hahn , Claudia Höhne , Adrian Klein ^*, Ilka Theruvath , Bernd Donaubauer , Thilo Busch  and Willehad Boemke ^*

^* Department of Anaesthesiology and Intensive Care Medicine, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany; Department of Anaesthesiology and Intensive Care Medicine, Evangelisches Waldkrankenhaus Spandau, Berlin, Germany; Department of Anaesthesiology and Intensive Care Medicine, Universitätsklinikum Leipzig, Germany; Department of Anesthesia and Postoperative Medicine, Medical University of South Carolina, Charleston, South Carolina, USA

Correspondence: Dr R C E Francis, AG Experimentelle Anästhesie, Klinik für Anästhesiologie und operative Intensivmedizin, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. Email: roland.francis{at}charite.de; roland.francis{at}gmx.de

The noble gas xenon seems to have minimal cardiovascular side-effects and so may be an ideal anaesthetic agent when investigating cardiovascular physiology. In comparison with standard modern anaesthetics, we investigated the haemodynamic and hormonal effects of xenon in Beagle dogs. After a 30 min baseline period, anaesthesia was induced with propofol and maintained with either (1) 1.2% isoflurane/70% nitrous oxide (N₂O), (2) 0.8% isoflurane/0.5 µg/kg/min remifentanil or (3) 63% xenon/0.5 µg/kg/min remifentanil (n = 6 per group). Haemodynamics were recorded and blood samples taken before and 60 min after induction. Mean arterial blood pressure (MAP) was higher in conscious dogs than during isoflurane/N₂O (86 ± 2 vs. 65 ± 2 mmHg, mean ± SEM) and isoflurane/remifentanil anaesthesia (95 ± 2 vs. 67 ± 3 mmHg), whereas MAP did not decrease significantly in response to xenon/remifentanil anaesthesia (96 ± 4 vs. 85 ± 6 mmHg). Bradycardia was present during isoflurane/remifentanil (54 ± 2/min) and xenon/remifentanil (40 ± 3/min), but not during isoflurane/N₂O anaesthesia (98 ± 3/min, P < 0.05). Xenon/remifentanil anaesthesia induced the highest reduction in cardiac output (CO) (–61%), and the highest increase in systemic vascular resistance (+120%) among all treatment groups (P < 0.05). A simultaneous increase in endogenous adrenaline and noradrenaline concentrations could only be observed in the xenon/remifentanil group, whereas angiotensin II and vasopressin concentrations increased in all groups. In conclusion, xenon/remifentanil anaesthesia maintains MAP but reduces heart rate and CO and is associated with a considerable stimulation of vasopressor hormones in Beagle dogs. Therefore, xenon/remifentanil exerts a new quality of adverse haemodynamic effects different from volatile anaesthetics and may not perform better during studies of cardiovascular physiology.

Key Words: Anaesthesia • cardiovascular • haemodynamic • catecholamine • xenon

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?